Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
Impinj
- The Trade: Impinj, Inc. PI Director Patrick Daniel Gibson acquired a total of 63,672 shares shares an average price of $60.51. To acquire these shares, it cost around $3.85 million.
- What’s Happening: Impinj posted upbeat second-quarter results.
- What Impinj Does: Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications.
2seventy bio
- The Trade: 2seventy bio, Inc. TSVT 10% owner Yue Tang acquired a total of 601,828 shares at an average price of $5.92. To acquire these shares, it cost around $3.56 million.
- What’s Happening: 2seventy bio reported a narrower second-quarter loss.
- What 2seventy bio Does: 2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer.
Don’t forget to check out our premarket coverage here
Healthcare Realty Trust
- The Trade: Healthcare Realty Trust Incorporated HR Director Knox John Singleton bought a total of 31,500 shares at an average price of $17.11. To acquire these shares, it cost around $538,965.
- What’s Happening: Healthcare Realty Trust posted upbeat second-quarter sales.
- What Healthcare Realty Trust Does: Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties.
Check This Out: Top 5 Consumer Stocks That May Fall Off A Cliff
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.